Radiofrequency ablation (RFA) is a minimally invasive procedure used to reduce pain by applying an electrical current produced by radio waves to heat up a small area of nerve tissue or to kill cancer cells. Radiofrequency ablation procedure involves a local anesthetic and mild sedation. The RF ablation technology for pain management involves the ablation of nerves in and around the affected tissue that cause excruciating chronic pain. This procedure is primarily used to reduce chronic lower back and neck pain caused due to degeneration of joints (due to arthritis and other spinal conditions). The procedure involves heating a small area of nervous tissue under controlled temperature resulting in blockage of pain signals transmitting from that area, and thereby relieving the patient from chronic pain.
The global radiofrequency ablation devices market report provides market size estimates (Revenue US$ million – 2014 to 2021) for key market segments based on the type of device used (capital equipment; disposable products such as cannula, needles, single use electrodes and probes; and reusable electrodes and probes, etc.), and forecasts growth trends (CAGR% – 2017 to 2021).
The global radiofrequency ablation devices market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global radiofrequency ablation devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global radiofrequency ablation devices market and included in this report are AngioDynamics, Covidien (Medtronic, Inc.), Boston Scientific Corporation, Cosman Medical, Halyard Health, Inc., and St. Jude Medical.